Log In
BCIQ
Print this Print this
 

AMG 780

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman anti-angiopoietin antibody
Molecular Target Angiopoietin 1 (ANG1) (ANGPT1) ; Angiopoietin 2 (ANG2) (ANGPT2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today